Homocysteine: the marker that sits between heart and nutrition

Homocysteine sits at an intersection: part cardiovascular marker, part nutritional readout, and a case study in why association and causation are different things.

What homocysteine is

Homocysteine is an amino acid produced as an intermediate step when the body processes methionine, an amino acid from dietary protein. It is not meant to accumulate — the body recycles it onward, and the recycling machinery runs on B vitamins: folate and B12 chiefly, with B6 assisting.

That dependency is the key to the marker. When the B-vitamin machinery is short of parts, homocysteine backs up — which makes a raised level less a disease in itself than a signal that the recycling is struggling.

The cardiovascular story, told honestly

Raised homocysteine is associated with higher cardiovascular risk in observational research — that finding is consistent. The complication came from the intervention trials: lowering homocysteine with B vitamins reliably lowers the number, but large trials largely failed to show the expected reduction in heart attacks and strokes.

The likely reading is that homocysteine is more marker than mechanism — a signpost of processes that raise risk rather than the engine of the risk itself. That is why it never became a routine cardiovascular test, and why it earns its place in specific situations rather than on every panel.

When it's genuinely useful

As a functional B-vitamin check. Serum B12 and folate measure what is circulating; homocysteine reflects whether enough is getting through to do the work. A raised level can expose a functional deficiency that borderline serum results leave ambiguous — this is its most practical everyday use.

In specific clinical contexts — certain clotting and vascular investigations, and a rare inherited condition of homocysteine metabolism — where it is ordered and interpreted by the treating doctor.

What moves it

Upward: folate or B12 deficiency, reduced kidney function, an underactive thyroid, some medications, smoking, and common gene variants affecting the folate pathway — usually modestly. Downward: adequate B-vitamin status, which in Australia and New Zealand is helped along by folic acid fortification of bread-making flour.

What homocysteine won't tell you

• It isn't a heart risk score. The association is real; treating the number has not been shown to prevent events.
• It doesn't name the deficiency. A raised level says the pathway is short; B12 and folate testing says which part.
• It doesn't justify blind supplementation. The response to a raised level is finding the cause with a doctor — especially since B12 deficiency masked by folate is the classic trap.
• Genetic curiosity isn't clinical need. Common pathway variants rarely change management; the measured level matters more than the genotype.

The bottom line

Homocysteine is most useful as a functional window on B-vitamin status, and most misleading when read as a standalone heart risk number. It is a marker with a specific job — and knowing the job is what makes it worth measuring.